Catalyst Brief

← Calendar

Readoutin 45d

Telix Pharmaceuticals (Innovations) Pty Limited — 68Ga-PSMA-11

Phase 3 primary completion: PSMA PET Combined With MRI for the Detection of PCa.

Date
Jan 2027
Type
Readout
Indication
PCA

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.